A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This work describes methods to establish acute and chronic hyperglycemia models in zebrafish. The aim is to investigate the impact of hyperglycemia on physiological processes, such as constitutive and injury-induced neurogenesis. The work also highlights the use of zebrafish to follow radiolabeled molecules (here, [18F]-FDG) using PET/CT.
Hyperglycemia is a major health issue that leads to cardiovascular and cerebral dysfunction. For instance, it is associated with increased neurological problems after stroke and is shown to impair neurogenic processes. Interestingly, the adult zebrafish has recently emerged as a relevant and useful model to mimic hyperglycemia/diabetes and to investigate constitutive and regenerative neurogenesis. This work provides methods to develop zebrafish models of hyperglycemia to explore the impact of hyperglycemia on brain cell proliferation under homeostatic and brain repair conditions. Acute hyperglycemia is established using the intraperitoneal injection of D-glucose (2.5 g/kg bodyweight) into adult zebrafish. Chronic hyperglycemia is induced by immersing adult zebrafish in D-glucose (111 mM) containing water for 14 days. Blood-glucose-level measurements are described for these different approaches. Methods to investigate the impact of hyperglycemia on constitutive and regenerative neurogenesis, by describing the mechanical injury of the telencephalon, dissecting the brain, paraffin embedding and sectioning with a microtome, and performing immunohistochemistry procedures, are demonstrated. Finally, the method of using zebrafish as a relevant model for studying the biodistribution of radiolabeled molecules (here,[18F]-FDG) using PET/CT is also described.
Hyperglycemia is defined as excessive blood glucose levels. Although it could reflect a situation of acute stress, hyperglycemia is also a condition that often leads to a diagnosis of diabetes, a chronic disorder of insulin secretion and/or resistance. In 2016, the number of adults living with diabetes has reached 422 million worldwide, and each year, 1.5 million people die from this disease, making it a major health problem1. Indeed, uncontrolled diabetes leads to several physiological disorders affecting the cardiovascular system, kidneys, and the peripheral and central nervous systems.
Interestingly, acute and chronic hyperglycemia may alter cognition and contribute to both dementia and depression2,3,4,5,6. In addition, the admission of patients with hyperglycemia has been associated with worse functional, neurological, and survival outcomes after ischemic stroke7,8,9,10,11. It was also shown that hyperglycemia/diabetes affect adult neurogenesis, a process leading to the generation of new neurons, by impacting neural stem cell activity and neuronal differentiation, migration, and survival2,12.
In contrast to mammals, teleost fish, like zebrafish, display intense neurogenic activity throughout the whole brain and exhibit an outstanding capacity for brain repair during adulthood13,14,15,16. Notably, such capacities are possible due to the persistence of neural stem/progenitor cells, including radial glia and neuroblasts17,18,19. In addition, the zebrafish has recently emerged as a model for studying metabolic disorders, including obesity and hyperglycemia/diabetes20,21,22.
Although the zebrafish is a well-recognized model of hyperglycemia and neurogenesis, few studies have investigated the impact of hyperglycemia on brain homeostasis and cognitive function12,23. To determine the impact of hyperglycemia on constitutive and injury-induced brain cell proliferation, a model of acute hyperglycemia was created through the intraperitoneal injection of D-glucose. In addition, a model of chronic hyperglycemia was reproduced through the immersion of fish in water supplemented with D-glucose12. Zebrafish exhibit many advantages in research. They are cheap, easy to raise, and transparent during the first stages of development, and their genome has been sequenced. In the context of this work, they also display several additional advantages: (1) they share similar physiological processes with humans, making them a critical tool for biomedical research; (2) they allow for the quick investigation of the impact of hyperglycemia on brain homeostasis and neurogenesis, given their widespread and strong neurogenic activity; and (3) they are an alternative model, allowing for the reduction of the number of mammals used in research. Finally, zebrafish can be used as a model for testing the biodistribution of radiolabeled molecules and potential therapeutic agents using PET/CT.
The overall goal of the following procedure is to visually document how to set up models of acute and chronic hyperglycemia in zebrafish, use zebrafish to assess brain remodeling in hyperglycemic conditions, and monitor radiolabeled molecules (here, [18F]-FDG) using PET/CT.
Adult wildtype zebrafish (Danio rerio) were maintained under standard photoperiod (14/10 h light/dark) and temperature (28 °C) conditions. All experiments were conducted in accordance with the French and European Community Guidelines for the Use of Animals in Research (86/609/EEC and 2010/63/EU) and were approved by the local Ethics Committee for animal experimentation.
1. Establishing a Model of Acute Hyperglycemia in Zebrafish
2. Establishing a Model of Chronic Hyperglycemia in Zebrafish
3. Measuring Blood Glucose Levels in Zebrafish
4. Analyzing Brain Cell Proliferation Following Hyperglycemia
5. Imaging the Biodistribution of Radiolabeled Molecules by PET/CT in Zebrafish: Fluorodeoxyglucose ([18F]-FDG) to Analyze Glucose Metabolism
Using the procedures described in this article, the intraperitoneal injection of D-glucose (2.5 g/kg bodyweight) was performed on adult zebrafish and led to a significant increase in blood glucose levels 1.5 h after injection (Figure 1A). 24 h post-injection, the blood glucose levels were similar between D-glucose and PBS-injected fish12. For chronic treatment, zebrafish were immersed in D-glucose water (111 mM) and became hyperglycemi...
This work describes various methods to establish acute and chronic models of hyperglycemia in zebrafish. The main advantages of these procedures are that: (1) they allow for a reduction in the number of mammals used for research, (2) they are simple to set up and quick to implement, and (3) they are economical. Therefore, such models allow for the investigation of the impact of hyperglycemia on a large number of animals to study its impact on different physiological processes, including atherothrombosis, cardiovascular d...
No potential conflicts of interest were disclosed.
We greatly thank Direction des Usages du Numérique (DUN) from La Réunion University for editing the video (in particular, Jean-François Février, Eric Esnault, and Sylvain Ducasse), Lynda-Rose Mottagan for the voiceover, Mary Osborne-Pellegrin for proofreading the voice-over, and the CYROI platform. This work was supported by grants from La Réunion University (Bonus Qualité Recherche, Dispositifs incitatifs), Conseil Régional de La Réunion, European Union (CPER/FEDER), and Philancia association. ACD is a recipient of a fellowship grant from the Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche, La Réunion University (Contrat Doctoral).
Name | Company | Catalog Number | Comments |
1mL Luer-Lok Syringe | BD, USA | 309628 | |
4',6'-diamidino-2-phenylindole (DAPI) | Sigma-Aldrich, Germany | D8417 | |
7 mL bijou container plain lab | Dutscher, France | 080171 | |
D-glucose | Sigma-Aldrich, Germany | 67021 | |
Digital camera | Life Sciences, Japan | Hamamatsu ORCA-ER | |
Disposable base molds | Simport, Canada | M475-2 | |
Donkey anti-rabbit Alexa fluor 488 | Life Technologies, USA | A21206 | |
Embedding center | Thermo Scientific, USA | Shandon Histocentre 3 | |
Fluorescence microscope | Nikon, Japan | Eclipse 80i | |
Fluorodeoxyglucose (18F-FDG) | Cyclotron, France | ||
Glucometer test strip | LifeScan, France | One-Touch 143 Ultra | |
Goat anti-mouse Alexa fluor 594 | Life Technologies, USA | A11005 | |
In-Vivo Imaging System | TriFoil Imaging, Canada | Triumph Trimodality | |
Microtome | Thermo Scientific, USA | Microm HM 355 S | |
Monoclonal mouse anti-PCNA | DAKO, USA | clone PC10 | |
Paraformaldehyde (PFA) | Sigma-Aldrich, Germany | P6148-500G | |
Polyclonal rabbit anti-GFAP | DAKO, USA | Z033429 | |
Slide drying bench | Electrothermal, USA | MH6616 | |
Sodium chloride | Sigma-Aldrich, Germany | S9888 | |
Sodium citrate trisodium salt dehydrate | Prolabo, France | 27833.294 | |
Sterile needle | BD Microlance 3 | 30 G 1/2 ; 0.3 mm× 13 mm | |
Student Dumont #5 Forceps | Fine Science Tools | 91150-20 | |
Student surgical scissors | Fine Science Tools | 91400-14 | |
Superfros Plus Gold Slides | Thermo Scientific, USA | FT4981GLPLUS | |
Surgical microscope | Leica, France | M320-F12 | |
Tissue embedding cassettes | Simport, Canada | M490-10 | |
Tissue embedding medium | LeicaBiosystems, USA | 39602004 | |
Toluene | Sigma-Aldrich, Germany | 244511 | |
Tricaine MS-222 | Sigma-Aldrich, Germany | A5040 | |
Triton X100 | Sigma-Aldrich, Germany | X100-500 mL | |
Vectashield medium | Vector Laboratories, USA | H-1000 | |
Xylene | Sigma-Aldrich, Germany | 534056 | |
Fish Strain | AB | ||
Saline phosphate buffer (10X PBS) pH 7.4 (for 1 liter) | For preparing 10X PBS, add the following salts and complete to 1 liter with distilled water | ||
Potassium chloride (MM : 74.55 g/mol): 2.00 g | Sigma-Aldrich, Germany | 746436 | |
Potassium phosphate monobasic (MM: 136,09 g/mol): 2.40g | Sigma-Aldrich, Germany | 795488 | |
Sodium chloride (MM : 58.44 g/mol): 80.00 g | Sigma-Aldrich, Germany | S9888 | |
Sodium phosphate dibasic (MM: 141,96 g): 14,40 g | Sigma-Aldrich, Germany | 795410 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved